p53 activates transcription of genes with a p53 response element, and it can repress genes lacking the element. Here we demonstrate that wild-type but not mutant p53 Inhibits transcription in a HeLa nuclear extract from minimal promoters. Wild-type but not mutant p53 binds to human TATA-binding protein (TBP). p53 does not bind to yeast TBP, and it cannot Inhibit tscription in a HeLa extract where yeast TBP subsitutes for hun TBP. These results suggest a model in which p53 binds to TBP and interferes with transcriptional initiation.
The p53 gene product functions as a transcription factor. It can activate transcription when bound to a promoter through a heterologous DNA-binding domain (1, 2) . Wild-type p53 (p53wt) binds to DNA sequences termed p53 response elements (3, 4) , and when these binding sites are adjacent to a minimal promoter, they stimulate expression in a p53-dependent fashion (5) (6) (7) (8) . p53wt also negatively regulates a variety of genes that lack a p53 response element, including the c-fos, c-jun, retinoblastoma, interleukin 6 , and proliferating cell nuclear antigen genes as well as the p53 gene itself (9) (10) (11) (12) . Expression of a class I major histocompatibility complex gene (9) and the Ha-rasl gene (13, 14) , however, are reportedly neither activated nor repressed by p53wt. Thus, it appears that p53wt may exert positive or negative effects on the expression of some but not all genes, and this may form the mechanistic basis for its ability to regulate cell proliferation.
Here we show that p53wt, but not mutant p53 (p53mt), inhibits transcription in nuclear extracts from minimal promoters. Furthermore, p53wt can bind directly to the human TATA-binding protein (TBP) . These results suggest that p53 functions as part of the transcriptional machinery, regulating transcription.
MATERIALS AND METHODS
Plasmids, Chioramphenicol Acetyltranserase (CAT) Assays, and Protein Purifiation. p11-4 encodes a murine pS3wt (m-p53wt) cDNA and pSVKH215 contains a m-p53mt cDNA with a four-amino acid insert at residue 215; both are controlled by the simian virus 40 early promoter (15) . pc53-CIN encodes a human p53wt (h-pS3wt) gene containing introns 2-4, under control of the cytomegalovirus immediate-early promoter, and pc53-Cx22AN is identical to pc53-CIN except that its coding region contains an Arg-175 to His substitution (16) . pTICAT (17) , p50-2 (8) , and pMLTATA (18) have been described. h-p53wt and His-175 h-p53mt cDNAs were subcloned into pETild DNA (19) to create pET-p53wt and pET-p53mt. Plasmids (phIIB; ref. 22) . CAT assays were performed as described (8) .
m-p53wt and KH215 m-p53mt proteins were purified from mammalian cells on an immunoaffinity matrix (23). They were -90%o pure, as determined by gel electrophoresis followed by silver staining. h-p53wt and His-175 h-p53mt (purified from baculovirus-infected Sf27 cells by immunoaffinity chromatography; ref. 6 ; gift of C. Prives, Columbia University, New York) were further purified by gel filtration, isolating monomeric p53 molecules. The proteins were >95% pure. h-p53wt and His-175 h-p53mt were also prepared from E. coli inclusion bodies. E. coli-produced h-p53wt and h-p53mt proteins were about 80%* and 95% pure, respectively. Human TFIIB (22) as well as human and yeast TBPs (24) were prepared from E. coli and further purified by gel filtration.
In Vito Transcription and Analysis of p53-TBP Interaction.
Nuclear extracts prepared by the method ofDignam et al. (25) received 100 ng of supercoiled template DNA. Where appropriate, the extract was heated at 470C for 15 min to inactivate endogenous TBP (26) . Reaction and primer-extension conditions were as described (27) 
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promoter. The effect of p53 on pTICAT expression was studied in human SAOS-2 cells, which do not contain endogenous p53 (30) . Cotransfection of SAOS-2 cells with pTICAT plus p11-4 (m-p53wt) caused a marked decrease (==20-fold) in CAT expression (Fig. 1A , compare lanes 1 and 2 to lanes 3 and 4). Cotransfection with pTICAT plus pSVKH215 (m-p53mt) caused only a modest decrease (-2.5-fold) in CAT expression (Fig. 1A , compare lanes 1 and 2 to lanes S and 6). m-p53mt exhibited significantly less inhibitory activity than the wild-type protein. In fact, this mutant p53 and others often produced no inhibitory effect in experiments in which a strong suppression was mediated by the wild-type protein. Like the murine protein, h-p53wt repressed expression from pTICAT, while a h-p53mt did not (Fig. 1B) . The inhibition caused by p53wt was not due to nonspecific toxicity. Cotransfection of SAOS-2 cells with p50-2 (a derivative of pTICAT with two p53 DNA-binding sites) and p114 (m-pS3wt) led to enhanced CAT expression as compared to transfection with pTICAT alone (8) . Thus, p53 can activate promoters that include a p53 response element and inhibit a minimal promoter lacking the site.
p53wt but Not p53mt Represses Transcription in Vitro. To demonstrate that the effect of p53 was direct and occurred at the level of transcription, we tested the ability of purified p53 to influence in vitro transcription. Nuclear extracts were prepared from HeLa cells, which contain low endogenous levels of p53 (31) . When 50 ng of m-p53wt (a temperaturesensitive protein purified in its wild-type conformation from transformed Al rat cells; ref. 32 ) was added to a reaction mixture containing pTICAT as template, the level of correctly initiated transcripts decreased (maximal repression was 8-fold: Fig The ability of p53wt to influence transcription was also tested using p50-2 as template (p53 response element up- stream from the minimal promoter in pTICAT). In vitro transcription directed by the p50-2 template was not altered by m-p53wt (Fig. 2D, lanes 1 and 2) , arguing that the repression of pTICAT promoter activity was not due to a nonspecific toxic effect of the m-p53. In contrast to m-p53, h-p53wt stimulated transcription from the p50-2 template (Fig. 2D, lanes 4-7) . This result fits with earlier findings that p53wt can stimulate transcription from p50-2 within transfected cells (8) and can stimulate the activity of promoters containing a p53 response element in cell-free extracts (6) . The different response of p50-2 to h-p53 as compared to m-p53 might be due to the oncogene product mdm-2 (33, 34) , which is present in the m-p53 but not h-p53 preparations. The mdm-2 protein forms a complex with p53 and blocks its ability to induce transcription through a p53 response element in transfected cells (23) .
In sum, m-p53wt or h-p53wt inhibited transcription from a minimal promoter, while two different mutant proteins had no effect.
p53 Interferes with Reactivation of T on by Human but Not Yeast TBP. The ability of p53 to suppress transcription directed by a minimal promoter raised the possibility that p53 might interact with TBP. To probe this hypothesis, TFIID activity was selectively inactivated (26) in a HeLa nuclear extract by heat treatment (Fig. 3A, compare lanes 1  and 3) . The decrease in transcription was partially rescued by the addition of recombinant human TBP (lane 4). Maximal restoration of activity was achieved by adding 20 ng of TBP. However, when human TBP was incubated with 50 ng or more of m-p53wt before addition to the heated extract, its ability to restore transcription was blocked (lanes 5-9). We also tested the ability of m-p53wt to inhibit restoration of transcription by yeast TBP. complex. Purified human TBP (produced in E. coli) was bound to Affi-Gel beads, producing an affinity matrix. When h-p53wt (purified from baculovirus-infected insect cells) was applied to the TBP matrix in buffer containing 50 mM KCl, 70-95% of it was retained in three independent experiments. It remained bound in buffer containing 0.1 M KCl and was eluted in 0.2 M KCl (Fig. 4A, lanes 1-6) . In contrast, h-pS3mt did not interact with the human TBP matrix (Fig. 4A, lanes  7-10) . The specificity of the interaction was confirmed by first binding h-p53wt to the TBP matrix and then washing with binding buffer containing a 100-fold excess of human TBP. In three independent experiments, 75-85% of the bound h-pS3wt was displaced from the TBP matrix and eluted with human TBP (Fig. 4B, lanes 1-3) , while none was eluted using yeast TBP (Fig. 4B, lanes 4-6) . h-p53wt did not bind at detectable levels to either yeast TBP or human TFIIB immobilized on beads (Fig. 4C) .
The human TBP affinity matrix experiment was repeated with h-p53 produced in E. coli rather than in baculovirusinfected insect cells. By producing both members of the complex in E. coli, the possibility that a third eukaryotic protein mediated the binding was eliminated. In three independent experiments, 70-80% ofthe E. coli-produced h-p53wt was retained on the human TBP affinity matrix (Fig. 4D, lanes  1-3) . The bound p53 was eluted by 0.2 M KCI (Fig. 4D, lane  3) , consistent with the results obtained using protein produced in baculovirus-infected cells (Fig. 4A) . As expected, p53mt (His-175) produced in E. coli was not retained on the TBP matrix (Fig. 4D, lanes 6 and 7) . Thus, h-p53wt but not h-pS3mt bound specifically and directly to human TBP on beads. The TBP-p53 interaction is weak in terms of its resistance to salt, but it was efficient in that most of the p53 was bound.
As a second test ofthe ability of pS3wt to bind human TBP, the purified monomeric proteins, either individually or after mixing, were subjected to gel filtration on an HPLC Sepharose 12 column. Either human TBP alone or h-p53wt alone eluted from the column in the vicinity of a 43-kDa marker p53wt (50 ng) was applied to hTBP beads, protein was eluted by incubation with 500 ng of purified hTBP or yTBP, and then the beads were boiled in 1% SDS. (C) p53wt does not bind to yTBP or human TFIIB (hTFIIB). p53wt (70 ng) was applied to TBP or hTFIIB beads; the beads were washed and then boiled in 1% SDS. (D) p53wt but not p53mt produced in E. coli binds to hTBP. p53 (100 ng) was applied to TBP beads and processed as in A. protein ( Fig. 5 A and B) . However, when the two proteins were mixed in a 1:1 molar ratio, a portion of each protein was present in a complex that exhibited a molecular mass of %92 kDa (Fig. 5C ). The complex was not formed when human TBP was mixed with h-pS3mt (Fig. SD) or when yeast TBP was mixed with h-p53wt (Fig. 5E) . Thus, human TBP and p53wt can form a specific complex in solution, whose size is consistent with the formation of a heterodimer.
As a final test of the ability of p53 to interact with TBP, a protein blot experiment (28, 35) was performed. Lysates were prepared from bacterial cells producing either h-p53wt or h-p53mt or from cells carrying the plasmid vector with no p53 insert. The proteins present in the three bacterial strains are displayed in Fig. 6 (lanes 2-4) . The difference in mobility of wild-type and mutant p53 is due to a Pro/Arg polymorphism at amino acid 72 (36), which has no known effect on function of the protein. A [35S]methionine-labeled human TBP probe bound to both h-pS3wt and h-p53mt proteins immobilized on a membrane (lanes 5-7). Although this experiment again argues that TBP and p53 can interact, it was surprising to observe an interaction with mutant p53. We suspect that the normally denatured mutant protein, or at least its TBPbinding domain, was renatured on the membrane. observation to a well-defined, minimal promoter (Fig. 1) . Our experiments provide several mechanistic insights to this inhibition. First, the inhibition was reproduced in cell-free extracts (Fig. 2) , demonstrating that p53 acts directly to repress transcription. Both m-p53wt and h-pS3wt proteins were able to mediate repression of a minimal promoter (Fig.  2 A and C) , while two p53mt proteins had no effect (Fig. 2 5-7) . Size markers are in kDa. and C). The repression was not due to nonspecific inhibition by p53wt, since a promoter containing a p53 response element was not inhibited and could be stimulated by the human protein (Fig. 2D) . Second, TBP is a target of p53-mediated repression. p53wt interfered with the ability of human TBP, but not yeast TBP, to reactivate a heat-treated extract (Fig.  3) . Third, p53wt can bind to human, but not yeast, TBP (Figs. 4 and 5) . The failure of p53 to bind yeast TBP is consistent with its inability to inhibit activity of the yeast protein (Fig.  3B ). The interaction with human TBP was shown using three assays: binding of p53 to TBP immobilized on beads (Fig. 4) , binding of p53 to TBP in solution followed by gel-filtration chromatography (Fig. 5) , and binding of TBP to p53 immobilized on a membrane (Fig. 6) . The binding is direct since purified p53 and TBP produced in E. coli interact (Fig. 4D) , and the size of the p53-TBP complex (92 kDa) suggests that it is a heterodimer (Fig. 5) .
p53 contains an acidic activating domain (1, 2) . The acidic activating domain of VP16 can inhibit transcription through an apparently nonphysiological process termed squelching (37) . High levels of VP16 are believed to bind and sequester one or more basal transcription factors, blocking their ability to enter into transcription complexes and inhibiting transcription of promoters that lack a VP16 binding site. It (9) and the Ha-rasi promoter (13, 14) 
